摘要
目的 探讨PCBP2在压力负荷诱导的小鼠心肌肥厚发生过程中的作用.方法 选取8~10周龄的雄性C57BL/6小鼠20只,体重23~28 g,随机分为2组,每组各10只,分别施以主动脉缩窄术(TAC组)和假手术(Sham组).术后4周应用超声心动图评价小鼠的心脏功能,应用心脏重量与体重之比(HW/BW)定量评价心肌肥厚程度.Real-time PCR检测心肌肥厚标志物Nppa、β-MHC (Myh7)的mRNA水平,同时检测PCBP2 mRNA水平.Western blot方法检测Nppa、β-MHC及PCBP2的蛋白水平.比较分析两组之间的差异.结果 与Sham组相比,TAC组小鼠的心肌肥厚程度明显增加[TAC组(8.23±1.88)mg/g比Sham组(4.89±0.68)mg/g],左心室射血分数[TAC组(41.38±2.22)%比Sham组(59.15±3.58)%]及短轴收缩率[TAC组(33.61±0.92)%比Sham组(43.87±1.37)%]明显降低(P<0.05).TAC组的心肌肥厚标志物Nppa、β-MHC的mRNA水平及蛋白水平均明显高于Sham组(P<0.05).然而,TAC组PCBP2mRNA水平及蛋白水平却明显低于Sham组(P<0.05),与心肌标志物Nppa、β-MHC的变化趋势相反.结论 PCBP2在压力负荷诱导的小鼠心肌肥厚发生过程中起着负性调节作用,上调PCBP2表达可能会抑制心肌肥厚的发展.
Objective The pressure overload cardiac hypertrophy was constructed by transaortic constriction(TAC ) in mice. To explore the effect of PCPB2 on the development of pressure overload cardiac hypertrophy in mice. Methods 20 male C57BL/6 mice (age 8-10 weeks, weight 23-28 kg) were used to construct the model. The mice were divided into 2 groups: TAC group(TAC surgery) and Sham group(Sham surgery). Cardiac function was evaluated by echocardiography at postoperative 4 weeks. Also, the degree of cardiac hypertrophy was assessed with the ratio of heart weight/body weight (HW/BW). Real-time PCR was used to detected the mRNA of PCBP2 and cardiac hypertrophic marker (Nppa,β-MHC). Western blot was used to examined the protein of PCBP2 and cardiac hypertrophic markers (Nppa, β-MHC). The differences between the two groups were analyzed. Results Compared with Sham group, cardiac hypertrophy and HW/BW ratio were significantly higher in TAC group[TAC group (8.23± 1.88 )mg/g vs Sham group (4.89±0.68)mg/g ], but cardiac function was lower in TAC group [ LVEF : TAC group (41.38±2.22)% vs Sham group (59.15±3.58)%; LVFS: TAC group (33.61±0.92)% vs Sham group (43.87±1.37)%(P〈0.05)]. The mRNA or proteins of Nppa and β-MHC of TAC group were higher than those of Sham group(P〈0.05). However, both the mRNA and protein of PCBP2 were significantly lower than those of Sham group(P〈0.05). Conclusion PCBP2 was a negative factor for the development of pressure overload cardiac hypertrophy in mice. Upregulation of PCBP2 may be able to inhibit the development of cardiac hypertrophy.
出处
《中国心血管病研究》
CAS
2016年第10期944-947,共4页
Chinese Journal of Cardiovascular Research
基金
国家临床重点专科项目(项目编号:)
上海申康医院发展中心新兴前沿技术项目(项目编号:SHDC12014107)
上海新华医院院级科研课题(项目编号:15YJ13)